Seven patients with bucco-lingual dyskinesia were treated with a single dose of ceruletide 0.8 gg/kg IM, a potent analogue of cholecystokinin octapeptide. Timecourse effects of the drug were then followed up to 6 weeks after injection in the longest case. To assess changes in severity of dyskinesia
Biphasic and long-lasting effect of ceruletide on tardive dyskinesia
β Scribed by Tadashi Nishikawa; Masatoshi Tanaka; Itsuyuki Koga; Yasunori Uchida
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 152 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
β¦ Synopsis
A 55-year-old schizophrenic inpatient with buccolingual dyskinesia was treated with a single dose of ceruletide 0.8 gg/kg IM. Time-course effects of the drug were then followed for up to 6 weeks after injection. To assess changes in severity of bucco-lingual dyskinesia objectively, electromyogram (EMG) and microvibration (MV) were recorded. Simultaneously, bucco-lingual dyskinesias were also evaluated by using a five-point rating scale. Before injection of ceruletide, severity of dyskinesia was "moderate" and 3-4 Hz of dyskinetic oral movements were dominant. "Extremely severe" and repetitious gross oral movements (around 1 Hz) were observed within a few minutes after injection and continued for up to 1 h. Thereafter, oral movements tended to decrease, and they disappeared completely 3 weeks after injection. This biphasic and long-lasting effect of ceruletide on tardive dyskinesia might contribute to further understanding of the physio-pathophysiological role of cholecystokinin-like peptides in the brain, and provide a basis for practical treatment of tardive dyskinesia.
π SIMILAR VOLUMES
## Abstract Unilateral pallidotomy has been effectively used to treat parkinsonism and reduce levodopa induced dyskinesia (LID). We sought to determine the longβterm effects of pallidotomy on LID in 10 patients who had initial benefit from pallidotomy but went on to require DBS surgery for symptom